Market Share Archives

Sanofi on path to immunology leadership as Dupixent milestones pile up

Blockbusters, Business, Consumer Health Care, Consumer Healthcare, Earnings per share (EPS), Financials, Forecasts, Forecasts, Market Share, Sales, Specialty Medicines, Therapeutics

Sanofi reported a series of first-quarter 2022 wins, driven mostly by the success of consumer healthcare (CHC) and the company’s blockbuster Dupixent.

Merck makes waves in Q1 2022 with COVID-19 treatment, cancer portfolio

Breakthrough Therapy Designation, Business, COVID-19 Therapeutic, COVID-19 Therapeutics, COVID-19 Therapies, Earnings per share (EPS), Financials, Forecasts, Keytruda, Market Share, Merck, Pneumococcal Conjugate Vaccines, Pneumococcal Vaccines, Sales, Therapeutics

Merck announced the company’s Q1 2022 results, reporting year-over-year revenue growth of 50 percent from continuing operations, with worldwide sales increasing to $15.9 billion. As anticipated, Merck’s COVID-19 antiviral treatment Lagevrio (molnupiravir) played a role in the company’s robust sales.

Rise of the biosimilars in the United States

IMS analysis revealed that lower-cost copies of complex biotechnology drugs could save the United States and Europe’s five top markets as much as €98 billion ($110 billion) by 2020.